Rockland Trust CO Abbott Laboratories Transaction History

Rockland Trust CO

  • $1.88 Billion
  • Q2 2024

A detailed history of Rockland Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, Rockland Trust CO holds 111,747 shares of ABT stock, worth $12.7 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
111,747
Previous 98,087 13.93%
Holding current value
$12.7 Million
Previous $11.1 Million 4.15%
% of portfolio
0.62%
Previous 0.6%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024
BUY
$100.73 - $112.44 $1.38 Million - $1.54 Million
13,660 Added 13.93%
111,747 $11.6 Million
Q1 2024

Apr 11, 2024
BUY
$109.52 - $120.96 $9,199 - $10,160
84 Added 0.09%
98,087 $11.1 Million
Q4 2023

Jan 11, 2024
BUY
$90.19 - $110.4 $553,315 - $677,304
6,135 Added 6.68%
98,003 $10.8 Million
Q3 2023

Oct 26, 2023
BUY
$95.53 - $114.62 $128,296 - $153,934
1,343 Added 1.48%
91,868 $8.9 Million
Q2 2023

Jul 27, 2023
SELL
$100.78 - $112.29 $708,382 - $789,286
-7,029 Reduced 7.21%
90,525 $9.87 Million
Q1 2023

Apr 24, 2023
BUY
$96.86 - $114.01 $103,640 - $121,990
1,070 Added 1.11%
97,554 $9.88 Million
Q4 2022

Jan 24, 2023
BUY
$95.06 - $111.52 $246,015 - $288,613
2,588 Added 2.76%
96,484 $10.6 Million
Q3 2022

Oct 19, 2022
BUY
$96.76 - $112.03 $182,392 - $211,176
1,885 Added 2.05%
93,896 $9.09 Million
Q2 2022

Jul 13, 2022
BUY
$102.07 - $123.37 $106,152 - $128,304
1,040 Added 1.14%
92,011 $10 Million
Q1 2022

Apr 18, 2022
BUY
$114.02 - $139.04 $761,881 - $929,065
6,682 Added 7.93%
90,971 $10.8 Million
Q4 2021

Jan 27, 2022
BUY
$115.53 - $141.46 $89,189 - $109,207
772 Added 0.92%
84,289 $11.9 Million
Q3 2021

Oct 25, 2021
BUY
$116.66 - $129.06 $498,138 - $551,086
4,270 Added 5.39%
83,517 $9.87 Million
Q2 2021

Jul 21, 2021
BUY
$105.79 - $124.53 $975,278 - $1.15 Million
9,219 Added 13.16%
79,247 $9.19 Million
Q1 2021

Apr 22, 2021
BUY
$108.84 - $128.23 $592,307 - $697,827
5,442 Added 8.43%
70,028 $8.39 Million
Q4 2020

Jan 04, 2021
SELL
$105.0 - $114.42 $553,455 - $603,107
-5,271 Reduced 7.55%
64,586 $7.07 Million
Q3 2020

Oct 08, 2020
SELL
$91.64 - $111.29 $350,523 - $425,684
-3,825 Reduced 5.19%
69,857 $7.6 Million
Q2 2020

Jul 09, 2020
SELL
$76.57 - $98.0 $108,423 - $138,768
-1,416 Reduced 1.89%
73,682 $6.74 Million
Q1 2020

Apr 16, 2020
BUY
$62.82 - $91.86 $254,735 - $372,492
4,055 Added 5.71%
75,098 $5.93 Million
Q4 2019

Jan 06, 2020
BUY
$78.51 - $87.4 $2.4 Million - $2.67 Million
30,585 Added 75.6%
71,043 $6.17 Million
Q3 2019

Oct 11, 2019
SELL
$81.84 - $88.74 $20,787 - $22,539
-254 Reduced 0.62%
40,458 $3.28 Million
Q2 2019

Jul 05, 2019
SELL
$72.88 - $85.0 $150,497 - $175,525
-2,065 Reduced 4.83%
40,712 $3.42 Million
Q1 2019

Apr 08, 2019
BUY
$66.22 - $80.06 $346,264 - $418,633
5,229 Added 13.93%
42,777 $3.42 Million
Q4 2018

Jan 16, 2019
SELL
$65.56 - $74.27 $583,746 - $661,300
-8,904 Reduced 19.17%
37,548 $2.72 Million
Q3 2018

Oct 05, 2018
SELL
$60.81 - $73.36 $1.55 Million - $1.87 Million
-25,493 Reduced 35.43%
46,452 $3.41 Million
Q2 2018

Jul 06, 2018
SELL
$57.57 - $63.54 $291,073 - $321,258
-5,056 Reduced 6.57%
71,945 $4.39 Million
Q1 2018

Apr 10, 2018
SELL
$56.27 - $63.62 $291,140 - $329,169
-5,174 Reduced 6.3%
77,001 $4.61 Million
Q4 2017

Jan 11, 2018
BUY
$53.68 - $57.47 $156,691 - $167,754
2,919 Added 3.68%
82,175 $4.69 Million
Q3 2017

Nov 01, 2017
BUY
$48.06 - $53.64 $3.81 Million - $4.25 Million
79,256
79,256 $4.23 Million

Others Institutions Holding ABT

# of Institutions
3,136
Shares Held
1.33B
Call Options Held
8.63M
Put Options Held
7.17M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Rockland Trust CO Portfolio

Follow Rockland Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockland Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Rockland Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email